Published in Sci Rep on December 21, 2015
Exchange factors directly activated by cAMP mediate melanocortin 4 receptor-induced gene expression. Sci Rep (2016) 0.76
Melanocortin receptor agonists MCR1-5 protect photoreceptors from high-glucose damage and restore antioxidant enzymes in primary retinal cell culture. J Cell Mol Med (2016) 0.75
HES1 promotes extracellular matrix protein expression and inhibits proliferation and migration in human trabecular meshwork cells under oxidative stress. Oncotarget (2017) 0.75
The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf (2007) 11.76
The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol (2006) 2.58
Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature (2014) 2.22
Advances in understanding and managing dry eye disease. Am J Ophthalmol (2008) 2.21
Distribution of mucins at the ocular surface. Exp Eye Res (2004) 2.20
Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjögren syndrome. Invest Ophthalmol Vis Sci (2002) 1.97
Leptin-receptor-expressing neurons in the dorsomedial hypothalamus and median preoptic area regulate sympathetic brown adipose tissue circuits. J Neurosci (2011) 1.82
Effect of inflammation on lacrimal gland function. Exp Eye Res (2005) 1.68
Functions of ocular surface mucins in health and disease. Curr Opin Allergy Clin Immunol (2008) 1.67
Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology (2005) 1.63
Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology (2008) 1.61
Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res (2004) 1.61
Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease. Prog Retin Eye Res (2012) 1.32
Dry eye syndromes. Chem Immunol Allergy (2007) 1.24
Hypothalamic proopiomelanocortin processing and the regulation of energy balance. Eur J Pharmacol (2011) 1.19
alpha-Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in leukocytes by modulating protein kinase A, p38 kinase, and nuclear factor kappa B signaling pathways. J Biol Chem (2003) 1.09
New tools for the evaluation of toxic ocular surface changes in the rat. Invest Ophthalmol Vis Sci (2007) 1.08
Effect of pro-inflammatory mediators on membrane-associated mucins expressed by human ocular surface epithelial cells. Exp Eye Res (2009) 1.05
Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review. Biol Psychiatry (2012) 1.05
Structure, function and regulation of the melanocortin receptors. Eur J Pharmacol (2011) 1.04
Atopic ocular surface disease: implications on tear function and ocular surface mucins. Cornea (2005) 1.04
The phenol red thread tear test: a cross-cultural study. Invest Ophthalmol Vis Sci (1993) 1.03
Early-life exposure to testosterone programs the hypothalamic melanocortin system. Endocrinology (2011) 1.01
The core mechanism of dry eye disease is inflammation. Eye Contact Lens (2014) 0.98
Melanocortin potentiates leptin-induced STAT3 signaling via MAPK pathway. J Neurochem (2009) 0.97
Inhibition of endotoxin-induced uveitis and potentiation of cyclooxygenase-2 protein expression by alpha-melanocyte-stimulating hormone. Invest Ophthalmol Vis Sci (2004) 0.97
Efficacy of a 2-month dietary supplementation with polyunsaturated fatty acids in dry eye induced by scopolamine in a rat model. Graefes Arch Clin Exp Ophthalmol (2009) 0.96
Genetic evidence for the role of Erk activation in a lymphoproliferative disease of mice. Proc Natl Acad Sci U S A (2009) 0.93
Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis. Invest Ophthalmol Vis Sci (2013) 0.92
Identification of the Raf-1 signaling pathway used by cAMP to inhibit p42/p44 MAPK in rat lacrimal gland acini: role in potentiation of protein secretion. Invest Ophthalmol Vis Sci (2010) 0.89
Role of cAMP inhibition of p44/p42 mitogen-activated protein kinase in potentiation of protein secretion in rat lacrimal gland. Am J Physiol Cell Physiol (2007) 0.89
Adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone induce secretion and protein phosphorylation in the rat lacrimal gland by activation of a cAMP-dependent pathway. Eur J Biochem (1982) 0.88
α-Melanocyte-stimulating hormone protects retinal vascular endothelial cells from oxidative stress and apoptosis in a rat model of diabetes. PLoS One (2014) 0.88
Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model. Graefes Arch Clin Exp Ophthalmol (2008) 0.87
Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways. Neurobiol Aging (2013) 0.87
Modulation of the JAK/ERK/STAT signaling in melanocortin-induced inhibition of local and systemic responses to myocardial ischemia/reperfusion. Pharmacol Res (2013) 0.85
Immunosuppressive activity of a novel peptide analog of α-melanocyte stimulating hormone (α-MSH) in experimental autoimmune uveitis. J Neuroimmunol (2011) 0.85
Soluble adenylyl cyclase mediates bicarbonate-dependent corneal endothelial cell protection. Am J Physiol Cell Physiol (2010) 0.85
The role and treatment of inflammation in dry eye disease. Int Ophthalmol (2014) 0.84
Changing trends in the treatment of dry-eye disease. Expert Opin Investig Drugs (2013) 0.84
Clinical staining of the ocular surface: mechanisms and interpretations. Prog Retin Eye Res (2014) 0.84
Intravitreal injection of ranibizumab and CTGF shRNA improves retinal gene expression and microvessel ultrastructure in a rodent model of diabetes. Int J Mol Sci (2014) 0.82
Melanocortins applied intravitreally delay retinal dystrophy in Royal College of Surgeons rats. Graefes Arch Clin Exp Ophthalmol (2003) 0.81
Superoxide dismutase 1 inhibits alpha-melanocyte stimulating hormone and ultraviolet B-induced melanogenesis in murine skin. Ann Dermatol (2014) 0.81
Keratoconjunctivitis sicca modifies epithelial stem cell proliferation kinetics in conjunctiva. Cornea (2007) 0.81
Role of cyclic AMP and Ca2+ in potentiation of rat lacrimal gland protein secretion. Invest Ophthalmol Vis Sci (1988) 0.81
α-Melanocyte-stimulating hormone prevents glutamate excitotoxicity in developing chicken retina via MC4R-mediated down-regulation of microRNA-194. Sci Rep (2015) 0.79
Effect of VIP on intracellular [Ca2+], extracellular regulated kinase 1/2, and secretion in cultured rat conjunctival goblet cells. Invest Ophthalmol Vis Sci (2013) 0.79
Role of IFN-γ in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells. J Leukoc Biol (2011) 0.78
Serine protease inhibitor A3K suppressed the formation of ocular surface squamous metaplasia in a mouse model of experimental dry eye. Invest Ophthalmol Vis Sci (2014) 0.78
The melanocortin receptor in the rat lacrimal gland: a model system for the study of MSH (melanocyte stimulating hormone) as a potential neurotransmitter. Eur J Pharmacol (1990) 0.78
A Pragmatic Approach to the Management of Dry Eye Disease: Evidence into Practice. Optom Vis Sci (2015) 0.78
Characterization of functional melanotropin receptors in lacrimal glands of the rat. Peptides (1990) 0.77
Purification, characterization, and localization of neuropeptides in the cornea. Peptides (1989) 0.76
Effects of alpha-MSH on corneal epithelial lesions in rats. Coll Antropol (2012) 0.75